Congo, Democratic Republic of the vs Cuba: Access to anti-retroviral drugs, female
Congo, Democratic Republic of the
78.0%
in 2024
Cuba
78.0%
in 2024
Congo, Democratic Republic of the rank
60th
Cuba rank
60th
Access to anti-retroviral drugs, female over time
- Congo, Democratic Republic of the
- Cuba
How they compare
Congo, Democratic Republic of the currently reports 78.0% against 78.0% in Cuba, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Cuba ahead.
Congo, Democratic Republic of the ranks 60th and Cuba ranks 60th of 141 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 14.0% | 12.0% | Cuba |
| 2010s | 25.7% | 50.9% | 25.2% | Cuba |
| 2020s | 70.2% | 76.2% | 6.0% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Congo, Democratic Republic of the or Cuba?
- Congo, Democratic Republic of the, at 78.0% against 78.0% in Cuba as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Congo, Democratic Republic of the and Cuba?
- 0.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Cuba?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo, Democratic Republic of the and Cuba rank globally for access to anti-retroviral drugs, female?
- Congo, Democratic Republic of the ranks 60th and Cuba ranks 60th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.